UnitedHealth Group Incorporated $UNH Shares Sold by Joel Isaacson & Co. LLC

Joel Isaacson & Co. LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,804 shares of the healthcare conglomerate’s stock after selling 737 shares during the period. Joel Isaacson & Co. LLC’s holdings in UnitedHealth Group were worth $1,811,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Citizens National Bank Trust Department grew its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH increased its stake in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Caitlin John LLC raised its stake in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Triumph Capital Management acquired a new stake in UnitedHealth Group during the second quarter worth about $1,324,000. Finally, Wealth Effects LLC lifted its position in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after buying an additional 591 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Truist Financial boosted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. KeyCorp reduced their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Finally, Royal Bank Of Canada dropped their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Trading Down 0.3%

Shares of UnitedHealth Group stock opened at $358.95 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company’s fifty day moving average price is $309.38 and its two-hundred day moving average price is $352.34. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market capitalization of $325.09 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.